Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HRH3 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | SH3GL2 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-09 |
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | OR2B11 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |